Detalhe da pesquisa
1.
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.
Ann Hematol
; 101(10): 2337-2345, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836007
2.
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis.
PLoS One
; 16(7): e0254253, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34234378